Bookmark and Share

News & Events

The University of Maryland School of Medicine's Angela Brodie, PhD, Is Recipient of the 2012 Pharmacia-ASPET Award

Tuesday, January 10, 2012

brodie_angela4.jpg
 Dr. Angela Brodie is being recognized for her life-saving cancer research.
 

Angela Hartley Brodie, PhD, a professor in the Department of Pharmacology & Experimental Therapeutics at the University of Maryland School of Medicine, is the recipient of the 2012 Pharmacia-ASPET Award for Experimental Therapeutics. The Pharmacia-ASPET Award for Experimental Therapeutics is given annually to recognize and stimulate outstanding research in pharmacology and experimental therapeutics—basic laboratory or clinical research that has had, or potentially will have, a major impact on the pharmacological treatment of disease. This award is funded by an endowment from Pharmacia (now Pfizer) and by ASPET.

Dr. Brodie earned her PhD, in Chemical Pathology from the University of Manchester, United Kingdom. After receiving her PhD, she received a fellowship from the NIH for postdoctoral training at Clark University and the Worcester Foundation for Experimental Biology in Massachusetts, where she became a staff scientist and later senior scientist. She would later join the University of Maryland as an Associate Professor in the Department of Pharmacology & Experimental Therapeutics in the School of Medicine. Now a full professor, she also has appointments in the Department of Physiology and at the University of Maryland Greenebaum Cancer Center.

Dr. Brodie’s major research interests are in breast cancer treatment and the development and use of aromatase inhibitors and new treatments for prostate cancer. She is an internationally recognized scientist for her pioneering research on aromatase inhibitors for treatment of breast cancer. Her discoveries have provided hope for women who were previously unresponsive to widely accepted forms of breast cancer treatment. Her pioneering studies led to the development of aromatase inhibitors that are now approved by the FDA for treatment of breast cancer. She has expanded her research to investigate inhibitors of androgen synthesis as potential agents for treating prostate cancer.

As testimony to her major research accomplishments she has been awarded many of the leading cancer awards, including the Susan G. Komen Breast Cancer Foundation’s Brinker International Award for Breast Cancer Research, the Landon Award from the American Association of Cancer Research, and the Kettering Prize from the General Motors Cancer Research Foundation. Dr. Brodie is also involved in the training of graduate students and postdoctoral fellows and teaches in medical and graduate pharmacology courses. She has served on many NIH and NCI study sections, as well as a reviewer and member of the integration panel for the U.S. Army Department of Defense Army Breast Cancer Program. She is also a member of the Advisory Board for the Komen Foundation.

Dr. Brodie was presented the 2012 Pharmacia-ASPET Award for Experimental Therapeutics on Saturday, April 21 at the ASPET Business Meeting/Awards Reception during the American Society for Pharmacology and Experimental Therapeutics/Experimental Biology (EB) 2012 Meeting at the San Diego Convention Center in San Diego, California.

Contact

Search Articles

Learn More


BrodieAwardApril2012_250.jpg
 Dr. Brodie being presented with her award.